Statin diabetogenicity: guidance for clinicians

Item

http://www.wikidata.org/entity/Q36888713

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Statin diabetogenicity: guidance for clinicians

@en

type

Item

label

Statin diabetogenicity: guidance for clinicians

@en

prefLabel

Statin diabetogenicity: guidance for clinicians

@en

P1476

Statin diabetogenicity: guidance for clinicians

@en

P2093

Kausik Ray

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.

Diabetes mellitus, fasting glucose, and risk of cause-specific death.

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

P2888

1475-2840-12-s1-s3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/1475-2840-12-S1-S3

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

12 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2013-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003826034

http://www.w3.org/2001/XMLSchema#string

P698

23819776

http://www.w3.org/2001/XMLSchema#string

P921

lipid metabolism disorder

type-2 diabetes

mechanism of action

cardiovascular disease

metabolic syndrome

dyslipidemias

maturity-onset diabetes of the young

P932

3668177

http://www.w3.org/2001/XMLSchema#string

Statin diabetogenicity: guidance for clinicians

about

P2860

P2860

Statin diabetogenicity: guidance for clinicians

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P407

P478

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P407

P478

P5008

P577

P6179

P698

P921

P932